Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Suraj Samtani, Mauricio Burotto, Juan Carlos Roman, Daniela Cortes-Herrera, Annerleim Walton-Diaz*

*Autor correspondiente de este trabajo

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

Resumen

Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).

Idioma originalInglés
Número de artículo1551
PublicaciónDiagnostics
Volumen11
N.º9
DOI
EstadoPublicada - 27 ago. 2021

Nota bibliográfica

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Huella

Profundice en los temas de investigación de 'Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer'. En conjunto forman una huella única.

Citar esto